Physician profile
Meghan J Dunning
NPI 1003513458
$2,114.51
in general payments reported to CMS, 2019-2025
10 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,644 · 2024: $219 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,221 · Food and Beverage: $893 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,220.89 |
| Food and Beverage | $892.62 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,739.32 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| E.R. Squibb & Sons, L.L.C. | $122.87 | 2025 | Camzyos |
| Boston Scientific Corporation | $69.38 | 2023-2025 | Resonate El Icd Vr, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.35 | 2024-2025 | Lifevest |
| Abbott Laboratories | $33.88 | 2024 | Assurity, Mitraclip |
| Sanofi-Aventis U.S. LLC | $33.84 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.88 | 2025 | Jardiance |
| Philips North America LLC | $18.74 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Merck Sharp & Dohme LLC | $17.93 | 2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $14.32 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Dunning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.